Literature DB >> 14736795

Heparin therapy in giant cell arteritis.

L M Buono, R Foroozan, M de Virgiliis, P J Savino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14736795      PMCID： PMC1772017          DOI： 10.1136/bjo.2003.021592

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  15 in total

1.  The Dunlop-Dottridge Lecture: The pathogenesis of giant cell arteritis.

Authors:  C M Weyand
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

2.  Color Doppler imaging of the eye and orbit. A synopsis of a 400 case experience.

Authors:  W E Lieb; P M Flaharty; A Ho; R C Sergott
Journal:  Acta Ophthalmol Suppl       Date:  1992

3.  Progressive anterior ischemic optic neuropathy due to giant cell arteritis despite high-dose intravenous corticosteroids.

Authors:  M L Slavin; A J Margolis
Journal:  Arch Ophthalmol       Date:  1988-09

4.  On the necessity of anticoagulant therapy during the initial phase of steroid treatment in giant cell arteritis.

Authors:  H Lévesque; N Cailleux; H Courtois
Journal:  Eur J Med       Date:  1993-03

Review 5.  Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells.

Authors:  H G Garg; B T Thompson; C A Hales
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-11       Impact factor: 5.464

6.  Steroid management in giant cell arteritis.

Authors:  C C Chan; M Paine; J O'Day
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

7.  Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients.

Authors:  E Liozon; F Herrmann; K Ly; P Y Robert; V Loustaud; P Soria; E Vidal
Journal:  Am J Med       Date:  2001-08-15       Impact factor: 4.965

8.  Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.

Authors:  M A González-Gay; R Blanco; V Rodríguez-Valverde; V M Martínez-Taboada; M Delgado-Rodriguez; M Figueroa; E Uriarte
Journal:  Arthritis Rheum       Date:  1998-08

9.  Visual prognosis in giant cell arteritis.

Authors:  P D Aiello; J C Trautmann; T J McPhee; A R Kunselman; G G Hunder
Journal:  Ophthalmology       Date:  1993-04       Impact factor: 12.079

10.  Visual recovery in two patients after intravenous methylprednisolone treatment of central retinal artery occlusion secondary to giant-cell arteritis.

Authors:  D C Matzkin; T L Slamovits; R Sachs; R M Burde
Journal:  Ophthalmology       Date:  1992-01       Impact factor: 12.079
View more
  6 in total

1.  [Giant cell arteritis (arteriitis temporalis, arteriitis cranialis)].

Authors:  D Schmidt; T Ness
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

Review 2.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

3.  Treatment of vision loss in giant cell arteritis.

Authors:  Ryan A Scheurer; Andrew R Harrison; Michael S Lee
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

Review 4.  The Treatment of Giant Cell Arteritis.

Authors:  Imran Jivraj; Madhura Tamhankar
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

5.  Clinical approach to optic neuropathies.

Authors:  Raed Behbehani
Journal:  Clin Ophthalmol       Date:  2007-09

6.  Development of an evidence-based regimen of prednisolone to treat giant cell arteritis - the Norwich regimen.

Authors:  Chetan Mukhtyar; Heidi Cate; Conor Graham; Peter Merry; Karen Mills; Aseema Misra; Colin Jones
Journal:  Rheumatol Adv Pract       Date:  2019-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.